Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies

Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies

Objectives: Disease-modifying therapies (DMTs) are applied to delay or prevent disease progression in multiple sclerosis (MS). While this has mostly been proven for physical symptoms, available studies regarding long-term effects of DMTs on cognitive functions are rare and sometimes inconsistent due...

Full description

Bibliographic Details
Main Authors: Kathrin S. Utz, De-Hyung Lee, Alexandra Lämmer, Anne Waschbisch, Ralf A. Linker, Thomas Schenk
Format: Article
Language:English
Published: SAGE Publishing 2016-07-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756285616643892

Similar Items

Similar Items